Gerome Breen (@psychgenomics) header
Gerome Breen (@psychgenomics) profile picture

Prof Psych Genetics (he/him) @KingsIoPPN NIHR MH BioResource. PI @edgi_uk, @GLADStudy, @covidcns. Gratitude: my wonderful TNG, Biobank groups @SGDPcentreKCL

King's College London
Joined May 2009
Photo by Gerome Breen (@psychgenomics)Photo by Gerome Breen (@psychgenomics)Photo by Gerome Breen (@psychgenomics)Photo by Gerome Breen (@psychgenomics)Photo by Gerome Breen (@psychgenomics)Photo by Gerome Breen (@psychgenomics)Photo by Gerome Breen (@psychgenomics)Photo by Gerome Breen (@psychgenomics)Photo by Gerome Breen (@psychgenomics)Photo by Gerome Breen (@psychgenomics)
GLAD is now >30,000 volunteers. Thanks to all of our participants, supporters, and all the researchers who have helped with recruitment in >200 clinical sites! If you have ever experienced depression or anxiety. @GLADStudy @NIHRBioResource @NIHRMaudsleyBRC
We would like to say a huge thank you to all of our participants who have taken the time to participate in the #GLADStudy and return their saliva kits! If you haven’t taken part yet and would like to you, you can sign up for the #GLAD Study at gladstudy.co.uk
4
15
1
65
Gerome Breen retweeted
How might we identify genes, cell types and molecular mechanisms of a complex trait/disease, when single cell gene expression data may never be available in the same cohorts we perform GWAS on, especially in cell types that are hard to access? 1/n
1
20
2
91
9,161
Kathy Stirrups presenting on @NIHRBioResource Long Read Sequencing including 22K participants - including 4K from @edgi_uk #ashg2026 - first data freeze available in Dec with more available via a Lifebit TRE early next year. Sequenced with @nanopore at @KCLGenomics and Cambridge.
3
3
575
Gerome Breen retweeted
I understand that people are demanding more access to products and control over their health, but unregulated peptides and “research use only” products are not worth it. There is a time and place to push boundaries but injecting yourself with something that is not proven or of an unknown source is not worth the risks.
Two souls are dead because they self administered something purporting to be the most powerful metabolic agent ever developed - without medical supervision, before the inventor has asked for approval and sourced from a Chinese “lab” seeking to make a quick buck. Peptide World - “Lilly made this up”.
16
14
4
63
16,634
📄 New preprint from ENCAP, the European Network for Clinical Application in Psychiatric Genomics: Recalculated CNV penetrance: what it does and does not change for counselling 🔗 doi.org/10.64898/2026.10.06.… 🧵 1/6
1
1
5
273
👨‍👩‍👧 Our view → give families phenotype-specific absolute risks alongside background risks, and leave reporting decisions to guideline bodies, locus by locus, across all relevant phenotypes. 5/6
1
30
🙏 A pleasure to work on this with psychiatrists, clinical geneticists and fellow scientists across ENCAP.
36
Gerome Breen retweeted
IQ points per watt: Humans: 5 AI: 0.000001
251
314
91
5,358
515,832
Gerome Breen retweeted
Every day I vacillate between which AI model I like more for science and which AI company's psychotic leaders & cults I hate more.
8
2
146
7,585
Gerome Breen retweeted
Exclusive: Nigel Farage filmed undercover celebrating secret new foreign donations Undercover footage verified by Channel 4 News reveals a secret plot by senior Reform UK figures to break the law on party donations. A leading legal expert is now calling for a criminal investigation. 🔗 Read the exclusive story on Substack: channel4news.substack.com/p/…
576
3,897
553
14,906
2,544,700
Gerome Breen retweeted
And…have difficulty being published. Our DREADD paper was rejected without review at multiple “high impact” journals …
Big ideas that change a lot (and sometimes lead to Nobels) almost by definition look like bad ideas when they are starting, but are actually good ideas… so people shouldn’t be surprised that a consensus driven org like NIH makes decisions like these
3
11
1
83
21,722
New research published in @NatMentHealth and led by @KingsIoPPN + @PGCgenetics is the largest genetic study of anorexia nervosa to date, and the first to compare the genetics of people with binge-eating behaviours to those without an eating disorder. maudsleybrc.nihr.ac.uk/news/…
3
4
419
Gerome Breen retweeted
It was basically too many risk points (vector, cargo,drug,indication,delivery,ROI) but I did not pursue this. It was mainly discussions with folks who wanted to commercialize it. Given that the basic platform is now being de-risked, anyone with a smidgen of imagination could go forward.
For years I’ve been asking my neuro colleagues why we hadn’t done clinical chemogenetics yet. Most said too pricey small or risky. Yet clearly the tech and the need are there. My take: VCs in the US are too big now — only social media (prev) or AI (now) have the scale they want.
2
3
1
34
15,053
Gerome Breen retweeted
Spain's mistake over Ceuta was merely unpreparedness. Europe's much bigger mistake was attacking a Member State under an external (and likely coordinated) aggression just to score some meaningless political points at home instead of rallying around it and defend European borders.
142
904
30
8,326
138,844
Gerome Breen retweeted
What just happened in Ceuta was an orchestrated power move against Spain using migrants as a weapon. Young, unemployed Moroccan men lured by social media groups with promises of a new life and literally bussed to the border and ushed across by Moroccan authorities, were met only by an array of cameras awaiting them. Almost all returned home the next day. We are in a new era of warfare where the new weapons of geopolitical power-plays are ai, disinformation, deepfakes, troll farms and the poor - and Spain just got sent a message. All the world is a stage.
271
3,917
103
13,936
478,213
Gerome Breen retweeted
Another question I'd have about the AI math breakthroughs is how they compare to the results you would have gotten if you'd budgeted the same amount of resources on human mathematicians and created incentives for them to go super hard on proofs.
182
62
32
2,103
342,903